Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 351

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Open access
Fusaroli, Michele, Salvo, Francesco, Begaud, Bernard, AlShammari, Thamir M., Bate, Andrew, Battini, Vera, Brueckner, Andreas, Candore, Gianmario, Carnovale, Carla, Crisafulli, Salvatore, Cutroneo, Paola Maria, Dolladille, Charles, Drici, Milou-Daniel, Faillie, Jean-Luc, Goldman, Adam, Hauben, Manfred, Herdeiro, Maria Teresa, Mahaux, Olivia, Manlik, Katrin, Montastruc, François, Noguchi, Yoshihiro, Norén, G. Niklas, Noseda, Roberta, Onakpoya, Igho J., Pariente, Antoine, Poluzzi, Elisabetta, Salem, Myriam, Sartori, Daniele, Trinh, Nhung T. H., Tuccori, Marco, van Hunsel, Florence, van Puijenbroek, Eugène, Raschi, Emanuel, Khouri, Charles·2024·Drug Safety

Abstract

In pharmacovigilance, disproportionality analyses based on individual case safety reports are widely used to detect safety signals. Unfortunately, publishing disproportionality analyses lacks specific guidelines, often leading to incomplete and ambiguous reporting, and carries the risk of incorrect conclusions when data are not placed in the correct context. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV) statement was developed to address this issue by promoting transparent and comprehensive reporting of disproportionality studies. While the statement paper explains in greater detail the procedure followed to develop these guidelines, with this explanation paper we present the 14 items retained for READUS-PV guidelines, together with an in-depth explanation of their rationale and bullet points to illustrate their practical implementation. Our primary objective is to foster the adoption of the READUS-PV guidelines among authors, editors, peer reviewers, and readers of disproportionality analyses. Enhancing transparency, completeness, and accuracy of reporting, as well as proper interpretation of their results, READUS-PV guidelines will ultimately facilitate evidence-based decision making in pharmacovigilance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40264-024-01423-7

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 351

Metadata

Authors
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M.-D., Faillie, J.-L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., Montastruc, F., Noguchi, Y., Norén, G. N., Noseda, R., Onakpoya, I. J., Pariente, A., Poluzzi, E., Salem, M., Sartori, D., Trinh, N. T. H., Tuccori, M., van Hunsel, F., van Puijenbroek, E., Raschi, E., & Khouri, C.
Venue
Drug Safety
Published
2024-05-07
Volume
47
Issue
6
Pages
585-599
ISSN
  • 0114-5916 (ISSN-L)
  • 1179-1942
OpenAlex
W4396696102
Cited by
351
References
72
FWCI
268.42
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. https://app.cochat.ai/papers/10.1007/s40264-024-01423-7
The paper
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M.-D., Faillie, J.-L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., . . . Khouri, C. (2024). The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. Drug Safety. https://doi.org/10.1007/s40264-024-01423-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.